Whey Protein: Forms, Grades & Independent Evidence on Muscle, MPS & Safety

Table of contents

• Evidence summary
• What whey protein is
• All forms and grades
• Protein quality: amino acids, leucine, DIAAS/PDCAAS
• How it works
• Benefits by claim
• What works and what does not
• Risks and all side effects
• All interactions
• Who should avoid whey protein
• Dosage and how to take
• Animal and in-vitro evidence excluded
• Independent funding and conflict notes
• Frequently asked questions
• Sources and funding notes

Evidence summary

Claim	Evidence	Source	Funding/conflict	Strength
Whey has the highest leucine density of common proteins (~11.0%, ~43% EAA)	Independent UPLC-MS/MS amino-acid analysis	Gorissen et al. 2018	TI Food & Nutrition (Dutch public-private, low conflict risk)	Strong
Whey isolate DIAAS ~1.09–1.20 (pig ileal model)	Digestibility study, in-vivo pig model	Mathai, Liu & Stein 2017	University of Illinois; no industry funding disclosed	Strong (flagged: pig model)
Whey PDCAAS 0.97–1.00, DIAAS ~0.90, limiting AA histidine	Compiled quality-score review/table	Hertzler et al. 2020	Abbott Nutrition-funded — flagged	Moderate
35 g whey maximally stimulates MPS in postmenopausal women; no gain at 60 g	Tracer dose–response RCT, muscle biopsies	Larsen et al. 2023	No industry funding disclosed	Strong
Leucine content, not protein grams, drives acute MPS	Tracer RCT, older women	Devries et al. 2018	PepsiCo R&D co-authors — flagged	Moderate
Native whey vs. WPC-80: no MPS advantage despite higher blood leucine	Double-blind RCT	Hamarsland et al. 2017	TINE (dairy company) supplied product — flagged	Moderate
Whey + resistance training improves muscle mass, gait speed in sarcopenia	Meta-analysis, 10 RCTs, 1,154 adults	Li et al. 2024	No industry funding disclosed	Moderate
Whey + training raises muscle mass/handgrip, but small effect, low GRADE	Meta-analysis, 7 RCTs, 591 adults	Cuyul-Vásquez et al. 2023	No industry funding disclosed	Moderate
Whey improves multiple type-2-diabetes risk factors	Umbrella review, 13 systematic reviews / 109 RCTs	Connolly et al. 2023	Purdue University; no industry funding	Strong
Whey pre-load lowers postprandial glucose via GLP-1/insulin	Meta-analysis, 5 RCTs, 134 people with T2DM	Chiang et al. 2022	Taipei Medical University / Cochrane Taiwan; no industry funding	Strong
High protein safe for healthy kidneys; caution advised in pre-existing CKD	Academic review	Ko et al. 2020	UC Irvine / NYU; no industry funding	Strong
No evidence whey harms the liver in healthy people	Narrative review	Cava et al. 2024	San Raffaele, Italy; no industry funding (lower-tier design)	Moderate
Whey use associated with higher acne prevalence (47% vs. 27.7%)	Case-control study, 201 young men	Alsulaimani et al. 2024	No industry funding disclosed	Moderate
~47% of tested protein powders exceed a heavy-metal safety threshold	Independent nonprofit lab testing, 165 products	Clean Label Project 2025	Nonprofit (donations + certification fees) — sells certification, treat rankings cautiously	Moderate
1.4–2.0 g/kg/day, 20–40 g/dose recommended for active people	Position stand	Jäger et al. 2017, ISSN	ISSN has substantial supplement-industry sponsorship — flagged	Moderate

What whey protein is

Whey is the liquid fraction separated from milk during cheese-making, then spray-dried into powder. It is the most extensively studied protein supplement on the market, with a multi-lab, independently replicated human evidence base spanning muscle protein synthesis (MPS), hypertrophy, strength, and glycemic control (Gorissen et al. 2018). Because it originates as a dairy by-product, its composition and quality vary considerably depending on how much further processing (filtration, ion-exchange, enzymatic hydrolysis) is applied after separation — which is why the market segments into distinct grades described below.

All forms and grades

Commercial whey products differ mainly by processing intensity, lactose/fat content, and final protein percentage:

Form/grade	Typical protein %	Processing	Lactose/fat content	Notes
Whey protein concentrate (WPC, incl. WPC80)	~34–80%	Ultrafiltration of whey liquid	Retains more lactose and milk fat	"WPC80" is the common sports-nutrition grade; cheapest to produce
Whey protein isolate (WPI)	≥90%	Microfiltration or ion-exchange	Most lactose and fat removed	Preferred by lactose-sensitive users; higher cost
Whey protein hydrolysate (WPH)	Similar to WPC/WPI base stock	Enzymatically pre-digested into shorter peptides	Low lactose (varies by base)	Marketed for faster absorption; often more bitter-tasting
Native whey	High-purity, comparable to WPI	Extracted directly from skim milk (not a cheese by-product) by filtration	Low lactose/fat	Higher leucine content than WPC-80, but see MPS section — no proven MPS advantage over WPC-80 (Hamarsland et al. 2017)

All grades derive from the same source protein, so their essential amino acid profile is similar per gram of protein; the practical differences for consumers are lactose tolerance, cost, and taste rather than fundamentally different anabolic potential.

Protein quality: amino acids, leucine, DIAAS/PDCAAS

Independent amino-acid analysis from the van Loon lab at Maastricht (using UPLC-MS/MS) measured whey isolate at ~43% essential amino acids (EAA) and ~11.0% leucine by weight — the highest EAA and leucine density of any common protein source, compared with 38% EAA in human skeletal muscle itself (Gorissen et al. 2018, Amino Acids; funded by TI Food and Nutrition, a Dutch public-private consortium — partially industry-adjacent, but the amino-acid measurements are analytical chemistry with low conflict risk).

On protein-quality scales, whey scores near the top of both systems:

• DIAAS (Digestible Indispensable Amino Acid Score): Using the pig ileal-digestibility reference method — the OECD/FAO-standard model for DIAAS (IN-VIVO PIG MODEL, flagged; pigs are used because their gut closely mirrors human ileal digestion and human ileal-cannulation studies are rare) — whey protein isolate had a DIAAS of ~1.09–1.20 (>100%) (Mathai, Liu & Stein 2017, Br J Nutr; University of Illinois; no industry funding disclosed in the abstract).
• PDCAAS (Protein Digestibility-Corrected Amino Acid Score): Whey scores approximately 1.00 under the same source.
• A separate independent review tabulated whey at PDCAAS 0.97–1.00 and DIAAS ~0.90, with histidine as the limiting amino acid (Hertzler et al. 2020, Nutrients — funded by Abbott Nutrition; flagged as industry-funded, though its DIAAS/PDCAAS table simply compiles previously published values).

Bottom line: across both the independent pig-model source and the industry-funded compilation table, whey lands consistently at or near the ceiling of both quality scales — the numeric range (0.90–1.20 depending on methodology) reflects differences in analytic approach, not a real dispute about whey's quality ranking.

How it works

Whey stimulates muscle protein synthesis (MPS) primarily by delivering a fast, large bolus of essential amino acids — particularly leucine — which activates the mTORC1 signaling pathway in skeletal muscle. MPS rises with protein/leucine dose up to a plateau, beyond which additional protein does not further stimulate synthesis within a single feeding window. This dose-response relationship has been measured directly in humans using L-[ring-¹³C₆]phenylalanine tracer infusions combined with muscle biopsies (Larsen et al. 2023). Leucine specifically appears to act as the biochemical "trigger" for this pathway rather than total protein mass being the determining factor (Devries et al. 2018, flagged for PepsiCo R&D co-authorship). Whey's digestibility and amino-acid release-rate scores (DIAAS) are derived from the pig ileal-cannulation model — an animal/in-vivo digestibility model, not a human trial — and are flagged as such throughout this article; they are used only to estimate amino-acid bioavailability, not to draw conclusions about human muscle or metabolic outcomes, which rest on the human tracer and RCT evidence below.

Benefits by claim

Muscle protein synthesis (MPS) dose-response

A recent independent dose-response tracer study in overweight postmenopausal women found myofibrillar MPS was maximally stimulated by 35 g whey (0.043%/h), with no further gain at 60 g, versus a submaximal response at 15 g — measured directly with an L-[ring-¹³C₆]phenylalanine infusion and muscle biopsies (Larsen et al. 2023, University of Birmingham; no industry funding disclosed — independent). In younger trained men, the plateau sits nearer 20 g per serving at rest and roughly 40 g after whole-body resistance exercise, consistent with the leucine-trigger model and higher total amino-acid demand following training.

Leucine as the anabolic trigger

An elegant McMaster study showed that 10 g of milk protein spiked to 3 g leucine stimulated acute myofibrillar MPS as much or more than 25 g whey isolate (also 3 g leucine) in older women — leucine content, not grams of protein, was the primary determinant (Devries et al. 2018, J Nutr). Funding/conflict flag: three co-authors were employed by PepsiCo R&D Nutrition (a protein-ingredient seller); lead academics were from McMaster (Phillips lab). The finding is nonetheless corroborated by independent tracer work elsewhere.

Native whey vs. WPC-80

A double-blind RCT (2×20 g post-exercise) found native whey raised blood leucine more than WPC-80 but produced similar MPS over 5 hours — extra leucine above the anabolic threshold did not translate into more muscle protein synthesis (Hamarsland et al. 2017, JISSN; Norwegian School of Sport Sciences; supplements supplied by TINE SA (dairy company) — partial industry involvement flagged). Practical takeaway: paying a premium for native whey is not supported by superior MPS outcomes once the leucine threshold is already met by standard WPC-80.

Hypertrophy and strength in older adults (sarcopenia)

Two independent meta-analyses of RCTs assessed whey's effect in sarcopenic populations:

• 10 RCTs, 1,154 sarcopenic older adults: whey significantly increased appendicular skeletal-muscle-mass index (SMD 0.47), muscle mass (SMD 0.28) and gait speed (SMD 1.13); adding resistance training improved handgrip strength (SMD 0.67) (Li et al. 2024, J Nutr Health Aging; China Medical University; no industry funding disclosed).
• 7 RCTs, 591 sarcopenic adults: whey plus resistance training raised muscle mass (SMD 0.24) and handgrip strength (+2.31 kg) versus training alone, but effect sizes were small, below the minimal clinically important difference, and GRADE quality was rated low to very low (Cuyul-Vásquez et al. 2023, Nutrients; Chilean/Brazilian universities; no industry funding).

Honest reading: whey reliably outperforms placebo for MPS and lean mass, but in frail older adults the real-world magnitude is modest and the evidence quality is graded low by the reviewers themselves — this is why sarcopenia is graded Moderate rather than Strong.

Glycemia and insulin

An umbrella review of 13 systematic reviews covering 109 unique RCTs concluded whey supplementation improves several type-2-diabetes risk factors, with 9 of 13 reviews rated high quality on AMSTAR-2 (Connolly et al. 2023, Curr Dev Nutr; Purdue University; no industry funding). A focused meta-analysis of 5 RCTs (134 people with type 2 diabetes) found whey pre-loads lower postprandial glucose by raising GLP-1 and insulin and slowing gastric emptying (Chiang et al. 2022, Nutr Res; Taipei Medical University / Cochrane Taiwan; no industry funding). This is a genuine, independently supported acute effect and is graded Moderate overall (strong for the acute glucose effect, but chronic disease-outcome data are more limited).

Satiety and weight management

Whey acutely increases satiety and reduces subsequent energy intake in short-term crossover trials, and a 2024 systematic review found whey supplementation can support modest fat-mass reduction in the context of resistance training or energy restriction (Whey protein weight-loss systematic review 2024, PMC). Effects are real but small and highly dependent on total-diet context — whey is not a standalone weight-loss intervention. Graded Moderate.

What works and what does not

Claim	Verdict	Evidence basis
Whey stimulates MPS in a dose-dependent, plateauing manner	Works — well established	Larsen 2023 tracer/biopsy RCT
More than ~35–40 g whey per single dose builds more muscle	Does not work — plateau effect	Larsen 2023; no further MPS gain at 60 g
Leucine content drives the anabolic response more than total grams	Works — supported	Devries 2018 (flag: PepsiCo)
Native whey builds more muscle than standard WPC-80	Does not work — no advantage shown	Hamarsland 2017 (flag: TINE)
Whey + resistance training improves lean mass/strength in sarcopenic adults	Works, but modest, low-certainty	Li 2024; Cuyul-Vásquez 2023 (low GRADE)
Whey lowers postprandial glucose as a pre-load	Works — supported	Chiang 2022; Connolly 2023
Whey alone causes meaningful weight loss without diet changes	Does not work — diet-context dependent	2024 systematic review
Whey damages healthy kidneys	Does not work as a harm claim — not supported	Ko et al. 2020
Whey damages the liver in healthy people	Does not work as a harm claim — no evidence	Cava et al. 2024
Whey use is associated with acne	Real association (not RCT-proven causation)	Silverberg 2012; Pontes 2013; Alsulaimani 2024

Risks and all side effects

Risk/side effect	Who is affected	Evidence	Severity/notes
Bloating, gas, GI discomfort (lactose)	Lactose-intolerant users of WPC	Mechanistically clear, clinically well-documented	Common; WPI and WPH are near-lactose-free and usually tolerated
Reversible hyperfiltration	Healthy kidney function	Ko et al. 2020, JASN	Not shown to cause CKD in healthy people; no independent human trial demonstrates causation
Possible acceleration of kidney function decline	People with pre-existing impaired kidney function	Ko et al. 2020, JASN	Caution advised in existing CKD; UC Irvine / NYU, academic, no industry funding
Liver harm	General population	Cava et al. 2024	No independent human evidence; "liver damage" claims trace to case reports confounded by anabolic-steroid use, not whey itself (narrative review, lower-tier evidence)
Acne onset/flare	Teenagers, gym users, young men	Silverberg 2012 (case series, n=5); Pontes 2013 (observational, n=30); Alsulaimani 2024 (case-control, n=201; 47% vs. 27.7% prevalence, p=0.0047)	Moderate — real signal via insulin/IGF-1 mechanism, but low-tier study designs (case reports, observational, case-control), not RCT-proven
Heavy-metal exposure (arsenic, lead, cadmium, mercury)	Users of contaminated powders	Clean Label Project 2025 (165 products, 70 brands, 35,862 data points)	47% of tested products exceeded at least one federal/state safety threshold; 21% exceeded 2× California Prop 65 levels; plant-based and "organic" powders carried the highest lead
Under-delivery of usable amino acids ("protein/nitrogen spiking")	Users of adulterated products	Nutritional Outlook / USP	Cheap free amino acids or non-protein nitrogen inflate the Kjeldahl/combustion protein test without delivering usable EAAs

All interactions

Substance/drug class	Interaction/mechanism	Severity	Evidence quality
Antidiabetic medications (insulin, sulfonylureas)	Whey pre-loads lower postprandial glucose via GLP-1/insulin; theoretical additive glucose-lowering effect when combined with glucose-lowering drugs	Monitor — theoretical, not established as clinically dangerous	Inferred from Chiang et al. 2022; no dedicated interaction trial identified
Levothyroxine and other drugs requiring empty-stomach dosing	Dairy-protein co-ingestion may reduce absorption of some oral medications, as is documented for other high-protein/dairy meals	Caution — separate dosing by several hours	Data gap specific to whey; general dairy/medication timing principle, not directly tested for whey in the research reviewed here
Nephrotoxic drugs (e.g., NSAIDs, certain antibiotics) in people with impaired kidney function	Both high protein load and nephrotoxic drugs stress renal function in CKD; combined effect not independently quantified for whey specifically	Caution in pre-existing CKD	Extrapolated from Ko et al. 2020; direct interaction data gap

Data gap note: Dedicated, independent human drug-interaction trials for whey protein are sparse. Most of the interaction cautions above are inferred from mechanistic or general nutrition-medicine timing principles rather than whey-specific RCTs. This is a genuine evidence gap, not proof of safety or danger.

Who should avoid whey protein

• People with a diagnosed milk/dairy protein allergy (distinct from lactose intolerance).
• People with lactose intolerance who choose WPC without switching to WPI/WPH, which are near-lactose-free.
• People with pre-existing chronic kidney disease (CKD), who should consult a nephrologist or dietitian before adding high-dose supplemental protein (Ko et al. 2020).
• People prone to acne or with active acne who notice a personal correlation with whey intake, given the documented association (Silverberg 2012; Pontes 2013; Alsulaimani 2024).
• Anyone seeking a vegan or strictly plant-based diet, since whey is a dairy-derived product.
• Buyers who cannot verify third-party testing (NSF Certified for Sport, Informed Sport) and are concerned about heavy-metal contamination or protein spiking, particularly if pregnant, nursing, or feeding children.

Dosage and how to take

Context	Dose	Timing	Leucine threshold	Source
Maximal MPS stimulation, postmenopausal/older women	35 g per dose (no further benefit at 60 g)	Single feeding	~3.5–4 g leucine (at ~11% leucine content)	Larsen et al. 2023
Resting-state dose, trained younger men	~20 g per serving	Any time; commonly between meals	~2–3 g leucine	Consistent with leucine-trigger model; Devries et al. 2018
Post whole-body resistance exercise, trained men	~40 g per serving	Within the post-exercise window	~4+ g leucine	Higher amino-acid demand following training
Minimum effective acute leucine trigger	~3 g leucine (achievable via 25 g whey isolate, or via smaller leucine-spiked doses)	Per feeding	3 g leucine threshold	Devries et al. 2018
General active-population daily target (ISSN position stand)	1.4–2.0 g protein/kg body weight/day (up to ~2.2 g/kg/day in a caloric deficit for muscle retention)	Spread across 20–40 g doses per meal/snack, roughly every 3–4 hours	~700–3,000 mg leucine per serving	Jäger et al. 2017, ISSN (flag: substantial supplement-industry sponsorship of ISSN)

Practical takeaway: for most adults, 20–40 g of whey per dose, timed around resistance training and/or spread across meals to reach 1.4–2.0 g/kg/day total protein, aligns with both the independent tracer studies and the (industry-sponsored) ISSN position stand. Doses meaningfully above ~40 g per single sitting do not appear to produce additional acute MPS benefit.

Animal and in-vitro evidence excluded

• Mathai, Liu & Stein 2017 (DIAAS methodology) — uses the pig ileal-digestibility model, the FAO/OECD reference standard for DIAAS because it closely mirrors human ileal digestion and human ileal-cannulation data are scarce. Excluded as human-trial proof of any muscle or clinical effect; values reported and flagged strictly as digestibility/protein-quality scoring (PubMed).

IN-VITRO / non-human evidence used: Only for digestibility/protein-quality scoring (DIAAS from the pig model above), always explicitly flagged, because human ileal-cannulation DIAAS data for whey are scarce. This model is not used anywhere in this article to claim a human muscle, satiety, glycemic, or safety effect — those conclusions rest exclusively on the human tracer studies and RCTs/meta-analyses cited in the Benefits and Risks sections.

Independent funding and conflict notes

Study	Design	Funding/conflict	Result
Gorissen et al. 2018	Independent amino-acid analysis (UPLC-MS/MS)	TI Food and Nutrition (Dutch public-private consortium); low conflict risk — analytical chemistry	Whey ~43% EAA, ~11.0% leucine, highest of common proteins
Mathai, Liu & Stein 2017	Pig ileal-digestibility DIAAS study	University of Illinois; no industry funding disclosed	Whey DIAAS ~1.09–1.20 (flag: pig model)
Hertzler et al. 2020	Compiled quality-score review	Abbott Nutrition-funded — flagged	Whey PDCAAS 0.97–1.00, DIAAS ~0.90, histidine-limiting
Larsen et al. 2023 (Birmingham)	Tracer MPS dose-response, women	No industry funding disclosed — independent	35 g = maximal MPS
Devries et al. 2018 (McMaster)	Tracer MPS, older women	PepsiCo R&D co-authors — flagged	Leucine is the trigger
Hamarsland et al. 2017 (Norway)	RCT native vs. WPC-80	Dairy company (TINE) supplied product — flagged	No MPS advantage of native whey
Li et al. 2024	Meta-analysis, 10 RCTs, sarcopenia	China Medical University; no industry funding	Whey improves muscle mass/gait speed
Cuyul-Vásquez et al. 2023	Meta-analysis, 7 RCTs, sarcopenia	Chilean/Brazilian universities; no industry funding	Small effect, low GRADE quality
Connolly et al. 2023	Umbrella review, 109 RCTs, T2DM	Purdue University; no industry funding	Improves glycemic risk factors
Chiang et al. 2022	Meta-analysis, 5 RCTs, T2DM	Taipei Medical University / Cochrane Taiwan; no industry funding	Lowers postprandial glucose
Ko et al. 2020	Academic review	UC Irvine / NYU; no industry funding	Safe in healthy kidneys; caution in CKD
Cava et al. 2024	Narrative review	San Raffaele, Italy; no industry funding (lower-tier design)	No evidence of liver harm in healthy people
Silverberg 2012	Case series, n=5	No industry funding disclosed	Acne cleared on stopping whey, flared on rechallenge
Pontes et al. 2013	Observational, n=30	No industry funding disclosed	Acne onset/worsening over 60 days
Alsulaimani et al. 2024	Case-control, n=201	No industry funding disclosed	47% vs. 27.7% acne prevalence (p=0.0047)
Clean Label Project 2025	Independent lab testing, 165 products	Nonprofit funded by donations and certification fees — sells certification, treat exact rankings cautiously	47% of products over a heavy-metal safety threshold
Nutritional Outlook / USP	Trade-press investigative report	Trade publication; underlying USP standards body	Documents nitrogen/amino spiking vulnerability
NSF Certified for Sport	Third-party certification program	NSF International; fee-based certification body	Tests ~290 WADA-banned substances, inspects facilities
Jäger et al. 2017, ISSN	Position stand	ISSN has substantial supplement-industry sponsorship; several authors employed by/consult for supplement companies — flagged	1.4–2.0 g/kg/day, 20–40 g/dose recommendation

Frequently asked questions

What's the difference between WPC, WPI, and WPH?

WPC (whey protein concentrate) retains more lactose and fat and ranges from about 34% to 80% protein by weight, with "WPC80" the common sports-nutrition grade. WPI (whey protein isolate) is filtered further to ≥90% protein with most lactose and fat removed, making it a better choice for lactose-sensitive users. WPH (whey protein hydrolysate) is enzymatically pre-digested into shorter peptides and marketed for faster absorption, though independent evidence that this translates into meaningfully more muscle protein synthesis than WPC or WPI at matched leucine doses is limited.

How much whey protein should I take per dose?

Independent tracer research found MPS is maximally stimulated by 35 g whey in postmenopausal women, with no additional benefit at 60 g (Larsen et al. 2023). In trained younger men, roughly 20 g at rest and up to about 40 g after whole-body resistance exercise appears sufficient. The ISSN position stand recommends 20–40 g per dose as a general guideline, though note this body carries substantial supplement-industry sponsorship (Jäger et al. 2017).

Does whey protein cause acne?

There is a real, if not RCT-proven, human signal linking whey intake to acne. A case series found acne cleared on stopping whey and flared on rechallenge in five teenaged athletes (Silverberg 2012); an observational study of 30 gym users saw acne onset or worsening over 60 days (Pontes et al. 2013); and a case-control study of 201 young men found whey users had significantly higher acne prevalence (47% vs. 27.7%, p=0.0047) (Alsulaimani et al. 2024). The proposed mechanism is whey's effect on insulin/IGF-1 signaling. Because these are case reports, observational, and case-control designs rather than RCTs, this is graded as a Moderate-strength association, not a proven cause.

Is whey protein safe for my kidneys?

In people with normal kidney function, high protein intake causes reversible hyperfiltration but no independent human trial shows it causes chronic kidney disease. The nuance is that high protein — especially animal protein — can worsen decline in people who already have impaired kidney function (Ko, Rhee, Kalantar-Zadeh & Joshi 2020, J Am Soc Nephrol). Verdict: safe for healthy kidneys; caution advised for those with existing CKD.

Are all whey protein powders contaminated with heavy metals?

Not all, but contamination is common industry-wide. Independent testing of 165 top-selling protein powders across 70 brands found 47% exceeded at least one federal/state safety threshold (such as California Prop 65) for arsenic, lead, cadmium, or mercury, and 21% exceeded twice the Prop 65 level. Notably, plant-based and "organic" powders carried the highest lead levels, not whey specifically (Clean Label Project 2025). Because Clean Label Project is a nonprofit that also sells certification, the population-level contamination finding is credible but exact brand-by-brand rankings should be treated cautiously and cross-checked against third-party batch testing like NSF Certified for Sport or Informed Sport.

How do I know if a whey protein product is genuinely high quality?

Look for third-party certification. NSF Certified for Sport tests for roughly 290 WADA-banned substances, reviews the formulation and label, and inspects manufacturing facilities — a standard required by MLB, NHL, and CFL for their players (NSF). Informed Sport / Informed Protein (LGC) batch-tests for banned substances and verifies label protein content. These certifications also guard against "nitrogen spiking," where cheap free amino acids or non-protein nitrogen are added to inflate the apparent protein content measured by standard Kjeldahl/combustion testing without delivering usable essential amino acids (Nutritional Outlook / USP).

Sources and funding notes

• Gorissen et al. 2018, Amino Acids (PMC6245118) — independent amino-acid analysis; funded by TI Food and Nutrition.
• Mathai, Liu & Stein 2017, Br J Nutr (PubMed 28382889) — pig ileal-digestibility DIAAS model, flagged as animal/in-vivo methodology; University of Illinois, no industry funding disclosed.
• Hertzler et al. 2020, Nutrients (PMC7760812) — funded by Abbott Nutrition; flagged as industry-funded.
• Larsen et al. 2023, University of Birmingham (PDF) — independent tracer dose-response study; no industry funding disclosed.
• Devries et al. 2018, J Nutr (PubMed 29901760) — flagged for PepsiCo R&D Nutrition co-authorship.
• Hamarsland et al. 2017, JISSN — flagged for TINE SA (dairy company) product supply.
• Li et al. 2024, J Nutr Health Aging (PubMed 38350303) — no industry funding disclosed.
• Cuyul-Vásquez et al. 2023, Nutrients (PMC10421506) — no industry funding disclosed.
• Connolly et al. 2023, Curr Dev Nutr (PMC10709019) — Purdue University, no industry funding.
• Chiang et al. 2022, Nutr Res (PubMed 35605541) — Taipei Medical University / Cochrane Taiwan, no industry funding.
• Whey protein weight-loss systematic review 2024 (PMC).
• Ko, Rhee, Kalantar-Zadeh & Joshi 2020, J Am Soc Nephrol (PMC7460905) — UC Irvine / NYU, no industry funding.
• Cava et al. 2024, Healthcare (PMC10815430) — San Raffaele, Italy; narrative review, no industry funding.
• Silverberg 2012, Cutis (PubMed 22988649).
• Pontes et al. 2013, An Bras Dermatol (PubMed 24474098).
• Alsulaimani et al. 2024, Clin Cosmet Investig Dermatol (PMC11022506).
• Clean Label Project 2025 Protein Study — nonprofit tester funded by donations and certification fees.
• Nutritional Outlook / US Pharmacopeia, protein spiking.
• NSF Certified for Sport program.
• Jäger et al. 2017, ISSN Position Stand: Protein and Exercise (PubMed 28642676) — flagged for substantial ISSN supplement-industry sponsorship and author industry ties.

Last reviewed: July 4, 2026.